| Abstract: | Lewis acid mediated skeletal rearrangement of the ingol diterpenoids 1 and 4 via regio‐ and stereospecific cyclopropane‐ring opening afforded the four new compounds 2, 3, 5 , and 6 , named nivulianol A–D (Scheme 1). Their structures were established by means of IR, MS, and in‐depth NMR spectroscopic analyses. The rearranged congeners were tested for lipopolysaccharide (LPS)‐induced prostaglandin (PG) E2 (cyclooxygenase‐2) inhibition. Thereby, nivulianol B (=(1S*,2E,4R*,5S*,7Z,9S*,11R,13S*,14S*)‐14‐acetoxy‐5‐methoxy‐3,9,13‐trimethyl‐6‐(1‐methylethenyl)‐10‐oxo‐15‐oxatricyclo9.3.1.01,11]pentadeca‐2,7‐dien‐4‐yl (2Z)‐2‐methylbut‐2‐enoate; 3 ) was found to be significantly active, with an IC50 value of 36.3 μg/ml. |
